Myomo (MYO) Free Cash Flow (2016 - 2025)
Myomo (MYO) reported Free Cash Flow of -$2.9 million for Q3 2025, down 58.78% on a YoY basis from -$7.0 million in Q3 2024, and up 73.3% quarter-over-quarter from -$10.8 million in Q2 2025.
Myomo (MYO) Free Cash Flow (2016 - 2025) Analysis & Trends
Myomo has reported Free Cash Flow for 10 years, with the latest figure at -$2.9 million in Q3 2025.
- For the quarter ending Q3 2025, Free Cash Flow fell 58.78% year-over-year to -$2.9 million; the trailing twelve-month figure through Dec 2025 stood at -$16.4 million (down 251.65% YoY), and the FY2024 full-year result was -$4.7 million, up 26.41% from the prior year.
- Free Cash Flow for Q3 2025 stood at -$2.9 million, up from -$10.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $2.5 million in Q4 2024, with the low at -$10.8 million in Q2 2025.
- Historically, Free Cash Flow has averaged -$2.5 million across 5 years, with a median of -$2.4 million in 2022.
- The largest YoY upside for Free Cash Flow was 204.95% in 2024 against a maximum downside of 577.31% in 2024.
- Myomo's Free Cash Flow stood at -$1.9 million in 2021, then plunged by 33.21% to -$2.5 million in 2022, then increased by 3.25% to -$2.4 million in 2023, then surged by 204.95% to $2.5 million in 2024, then tumbled by 215.01% to -$2.9 million in 2025.
- The last three Free Cash Flow figures came in at -$2.9 million (Q3 2025), -$10.8 million (Q2 2025), and -$2.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.88 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Mar 31, 2025 | -2.68 Mn |
| Mar 31, 2025 | -2.68 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | -1.81 Mn |
| Sep 30, 2024 | -1.81 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -3.31 Mn |
| Mar 31, 2024 | -3.31 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Jun 30, 2023 | -300,496.00 |
| Jun 30, 2023 | -300,496.00 |